Research and Markets has announced
the addition of Global Markets Direct's new company profile
"Alopecia - Pipeline Review, Q1 2011" to their offering.
Global Markets Direct's, 'Alopecia - Pipeline Review, Q1 2011',
provides an overview of the Alopecia therapeutic pipeline. This
report provides information on the therapeutic development for
Alopecia, complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Alopecia. 'Alopecia -
Pipeline Review, Q1 2011' is built using data and information
sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources, put together by Global
Markets Direct's team.
Note: Certain sections in the report may be removed or altered based
on the availability and relevance of data for the indicated disease.
Scope:
• A snapshot of the global therapeutic scenario for Alopecia.
• A review of the Alopecia products under development by companies
and universities/research institutes based on information derived
from company and industry-specific sources.
• Coverage of products based on various stages of development
ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.
• Coverage of the Alopecia pipeline on the basis of therapeutic
class, route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on
product description, mechanism of action and research & development
progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.
Reasons to Buy:
• Identify and understand important and diverse types of
therapeutics under development for Alopecia.
• Identify emerging players with potentially strong product
portfolio and design effective counter-strategies to gain
competitive advantage.
• Plan mergers and acquisitions effectively by identifying players
with the most promising pipeline.
• Devise corrective measures for pipeline projects by understanding
Alopecia pipeline depth and focus of Alopecia therapeutics.
• Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects
to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove them from
pipeline.
Back to hair loss news
Copyright stophairlossnow.co.uk